Finding of creatinine level
|
phenotype |
|
Finding
|
5
|
5
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
Spermatocytic seminoma
|
disease |
Neoplasms; Male Urogenital Diseases; Endocrine System Diseases
|
Neoplastic Process
|
9
|
2
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Psychoticism
|
disease |
|
Mental or Behavioral Dysfunction
|
11
|
2
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Urate nephropathy
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
16
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Hyperlactatemia
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
18
|
1
|
0.010 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
Contrast - Induced Nephropathy
|
disease |
|
Disease or Syndrome
|
19
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
aspirin intolerance
|
phenotype |
|
Sign or Symptom
|
23
|
4
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Lipoprotein (a) measurement
|
phenotype |
|
Laboratory Procedure
|
23
|
103
|
0.100 |
None |
1.000 |
1 |
2
|
2017 |
2017 |
T-cell/histiocyte rich large B-cell lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
28
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Xanthomatosis, Cerebrotendinous
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
40
|
71
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Nodular Lymphocyte Predominant Hodgkin Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
51
|
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2017 |
Nasal Type Extranodal NK/T-Cell Lymphoma
|
disease |
Neoplasms
|
Neoplastic Process
|
53
|
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Intrahepatic Cholestasis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
54
|
3
|
0.200 |
None |
1.000 |
1 |
|
2009 |
2009 |
Mediastinal (Thymic) Large B-Cell Lymphoma
|
disease |
Neoplasms; Respiratory Tract Diseases; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
66
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Histiocytic sarcoma
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
69
|
8
|
0.020 |
None |
0.500 |
2 |
|
2009 |
2010 |
Behavioral and psychological symptoms of dementia
|
phenotype |
|
Sign or Symptom
|
72
|
9
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Cholestasis, Extrahepatic
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
87
|
|
0.200 |
None |
1.000 |
1 |
|
2010 |
2010 |
Splenic Marginal Zone B-Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
93
|
4
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Psychiatric symptom
|
phenotype |
|
Sign or Symptom
|
95
|
12
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Pericardial effusion
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
98
|
10
|
0.010 |
None |
1.000 |
1 |
|
1996 |
1996 |
Cervical Squamous Intraepithelial Neoplasia
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
109
|
3
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Creatinine measurement, serum (procedure)
|
phenotype |
|
Laboratory Procedure
|
124
|
243
|
0.100 |
None |
1.000 |
6 |
4
|
2010 |
2019 |
Machado-Joseph Disease
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
135
|
12
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
145
|
21
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Linear atrophy
|
disease |
Pathological Conditions, Signs and Symptoms
|
Acquired Abnormality
|
149
|
6
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |